This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
06 JUNE
2025
World-First Breakthrough Leverages mRNA to Target HIV Cure
In a major advancement, Australian researchers have repurposed the mRNA delivery system from COVID-19 vaccines, aiming not to prevent HIV, but to help uncover a possible cure.Readmore
06 JUNE
2025
Research Breakthrough Brings Promise for ALS Treatment
A recent study challenges the notion that aberrant RNA splicing is the primary cause of ALS, proposing instead that the location of polyadenylation in RNA processing may play an equally critical role.Readmore
03 JUNE
2025
The gene in charge of cerebral and cranial formation
A recent study sheds light on why some leukemia patients fail to respond to treatment. Readmore
12 May
2025
Secarna Pharmaceuticals and Curie.Bio Portfolio Company Sign Research and Option Agreement
Secarna Pharmaceuticals GmbH & Co. KG, a leader in the discovery and development of next-generation oligonucleotide therapeutics, has announced the signing of a research and option agreement with a portfolio company of Curie.Bio. Readmore